Das Guillain-Barré-Syndrom und Langzeitdaten Karen Thiel2021-08-28T11:00:57+02:0028. August 2021|AstraZeneca, AstraZeneca-Impfstoff, covid-19, Covid-19-Impfstoffe, Covid-19-Impfung, Guillain-Barré-Syndrom, Healthcare allgemein, J&J, Janssen, Johnson & Johnson, mRNA-Impfstoff, Nebenwirkungen, Pharma Net Blog, SARS-CoV-2, Vektor-Impfstoff|
